187 related articles for article (PubMed ID: 10075058)
1. Pharmacokinetic and pharmacodynamic effects of high-dose continuous intravenous verapamil infusion: clinical experience in the intensive care unit.
De Cicco M; Macor F; Robieux I; Zanette G; Fantin D; Fabiani F; Nicolosi G; Fracasso A; Toffoli G; Santantonio C; Lestuzzi C; Matovic M; Boiocchi M
Crit Care Med; 1999 Feb; 27(2):332-9. PubMed ID: 10075058
[TBL] [Abstract][Full Text] [Related]
2. Non-linear pharmacokinetics of high-dose intravenous verapamil.
Toffoli G; Robieux I; Fantin D; Gigante M; Frustaci S; Nicolosi GL; De Cicco M; Boiocchi M
Br J Clin Pharmacol; 1997 Sep; 44(3):255-60. PubMed ID: 9296319
[TBL] [Abstract][Full Text] [Related]
3. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter.
Phillips BG; Gandhi AJ; Sanoski CA; Just VL; Bauman JL
Pharmacotherapy; 1997; 17(6):1238-45. PubMed ID: 9399606
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective pharmacokinetics and pharmacodynamics of verapamil and norverapamil in rabbits.
Mori Y; Hanada K; Mori T; Tsukahara Y; Hashiguchi M; Ogata H
Biol Pharm Bull; 2001 Jul; 24(7):806-10. PubMed ID: 11456122
[TBL] [Abstract][Full Text] [Related]
5. A combined accelerator mass spectrometry-positron emission tomography human microdose study with 14C- and 11C-labelled verapamil.
Wagner CC; Simpson M; Zeitlinger M; Bauer M; Karch R; Abrahim A; Feurstein T; Schütz M; Kletter K; Müller M; Lappin G; Langer O
Clin Pharmacokinet; 2011 Feb; 50(2):111-20. PubMed ID: 21142292
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of ranitidine in critically ill children.
Lugo RA; Harrison AM; Cash J; Sweeley J; Vernon DD
Crit Care Med; 2001 Apr; 29(4):759-64. PubMed ID: 11373465
[TBL] [Abstract][Full Text] [Related]
7. Disposition and pharmacologic effects of R/S-verapamil in patients with chronic atrial fibrillation: an investigation comparing single and multiple dosing.
Busse D; Fromm MF; Mörike K; Drescher S; Kühlkamp V; Eichelbaum M
Clin Pharmacol Ther; 2001 May; 69(5):324-32. PubMed ID: 11372000
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular effects of (R)- and (S)-verapamil and racemic verapamil in humans: a placebo-controlled study.
Busse D; Templin S; Mikus G; Schwab M; Hofmann U; Eichelbaum M; Kivistö KT
Eur J Clin Pharmacol; 2006 Aug; 62(8):613-9. PubMed ID: 16823584
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 3A5 genotype is associated with verapamil response in healthy subjects.
Jin Y; Wang YH; Miao J; Li L; Kovacs RJ; Marunde R; Hamman MA; Philips S; Hilligoss J; Hall SD
Clin Pharmacol Ther; 2007 Nov; 82(5):579-85. PubMed ID: 17443134
[TBL] [Abstract][Full Text] [Related]
10. The effect of food, time of dosing, and body position on the pharmacokinetics and pharmacodynamics of verapamil and norverapamil.
Gupta SK; Yih BM; Atkinson L; Longstreth J
J Clin Pharmacol; 1995 Nov; 35(11):1083-93. PubMed ID: 8626882
[TBL] [Abstract][Full Text] [Related]
11. The effect of gender on the pharmacokinetics of verapamil and norverapamil in human.
Dadashzadeh S; Javadian B; Sadeghian S
Biopharm Drug Dispos; 2006 Oct; 27(7):329-34. PubMed ID: 16892180
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular safety profile of combretastatin a4 phosphate in a single-dose phase I study in patients with advanced cancer.
Cooney MM; Radivoyevitch T; Dowlati A; Overmoyer B; Levitan N; Robertson K; Levine SL; DeCaro K; Buchter C; Taylor A; Stambler BS; Remick SC
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):96-100. PubMed ID: 14734457
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of verapamil: experience with a sustained intravenous infusion regimen.
Reiter MJ; Shand DG; Aanonsen LM; Wagoner R; McCarthy E; Pritchett EL
Am J Cardiol; 1982 Oct; 50(4):716-21. PubMed ID: 7124631
[TBL] [Abstract][Full Text] [Related]
14. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia.
Lim SH; Anantharaman V; Teo WS; Chan YH
Resuscitation; 2009 May; 80(5):523-8. PubMed ID: 19261367
[TBL] [Abstract][Full Text] [Related]
15. The pharmacodynamic and pharmacokinetic interaction between single doses of flecainide acetate and verapamil: effects on cardiac function and drug clearance.
Holtzman JL; Finley D; Mottonen L; Berry DA; Ekholm BP; Kvam DC; McQuinn RL; Miller AM
Clin Pharmacol Ther; 1989 Jul; 46(1):26-32. PubMed ID: 2501057
[TBL] [Abstract][Full Text] [Related]
16. Transient kinetic and dynamic interactions between verapamil and dofetilide, a class III antiarrhythmic.
Johnson BF; Cheng SL; Venitz J
J Clin Pharmacol; 2001 Nov; 41(11):1248-56. PubMed ID: 11697758
[TBL] [Abstract][Full Text] [Related]
17. Enhanced bioavailability of verapamil after oral administration with hesperidin in rats.
Piao YJ; Choi JS
Arch Pharm Res; 2008 Apr; 31(4):518-22. PubMed ID: 18449511
[TBL] [Abstract][Full Text] [Related]
18. Phase I study of vinblastine and verapamil given by concurrent iv infusion.
Benson AB; Trump DL; Koeller JM; Egorin MI; Olman EA; Witte RS; Davis TE; Tormey DC
Cancer Treat Rep; 1985; 69(7-8):795-9. PubMed ID: 4016789
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic modeling of the effects of oral and intravenous administrations of dofetilide on ventricular repolarization.
Le Coz F; Funck-Brentano C; Morell T; Ghadanfar MM; Jaillon P
Clin Pharmacol Ther; 1995 May; 57(5):533-42. PubMed ID: 7768076
[TBL] [Abstract][Full Text] [Related]
20. Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction.
Wagner F; Yeter R; Bisson S; Siniawski H; Hetzer R
Crit Care Med; 2003 May; 31(5):1421-8. PubMed ID: 12771613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
